Tuesday, August 11, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
MarketSouth Korea's Big Three Post ₩225.9B Q2 RevenuetodayMarketDaewoong's NABOTA Enters Seventh Middle East Market2 days agoRegulatoryBotox Masseter Indication Moves Closer to FDA OKtodayRegulatoryFDA Accepts BOTOX Masseter sBLA—Jawline Approval Path Clear2 days agoBusiness & M&AIndonesia Opens First Botulinum Toxin PlanttodayDevices & TechInMode Q2 Beats EPS Forecast, Revenue Tops Estimates2 days agoBusiness & M&AGalderma Raises 2026 Guidance After Robust H1todayBusiness & M&AEvolus Q2 Revenue Hits $84.1M, Raises 2026 Guidance2 days agoBusiness & M&AEvolus Posts Third Straight Profitable QuarteryesterdayRegulatoryFDA Accepts BOTOX Cosmetic sBLA for Masseter ProminenceyesterdayBusiness & M&AEvolus Q2 Revenue Surges 21%, Adjusted EBITDA Swings PositiveyesterdayBusiness & M&APerceptive Advisors Takes New Stake in Evolusyesterday
1 free article left this week. A free account gets you 4 a week.Go Pro →
Injectables

Skinvive by Juvéderm Wins FDA Approval for Neck — What's in Your Filler Mix Now

AbbVie's newest indication expands the Juvéderm franchise into a high-complaint zone; implications for your injectable protocol and patient conversation.

Image: Inside MedSpa
1-YEAR MOVE
+15% −13%
ABBV ▲11.6%
1-year price move by ticker
TickerCompany1-year change
ABBVAbbVie (Allergan Aesthetics)+11.6%

Allergan Aesthetics has secured FDA approval for Skinvive by Juvéderm for the improvement of neck appearance—specifically neck lines and skin texture. This marks the first and only FDA-cleared hyaluronic acid injectable designed specifically for neck treatment, a clinical gap that has forced practitioners to either use off-label filler or refer neck work elsewhere.

First and only FDA-cleared HA injectable designed specifically for the neck.

Skinvive is formulated with a lower concentration of cross-linked HA than traditional Juvéderm volumizers, optimized for the thinner, more mobile skin of the neck and décolletage. The approval rests on data showing sustained improvement in neck lines and skin quality at 12 weeks, with durability extending beyond six months in some patients. For practices already integrated into the Allē loyalty ecosystem, this represents a new SKU to stock and a new revenue stream—though neck treatment typically commands lower per-unit pricing than facial volumization. The real play: patient retention and case expansion in an area where competitors (Galderma, Revance) have not yet secured comparable cleared indications.

Source: original report ↗

Frequently asked questions

Is Skinvive by Juvéderm FDA approved for neck treatment?

Yes. Allergan Aesthetics secured FDA approval for Skinvive by Juvéderm specifically for improving neck appearance, including neck lines and skin texture. It is the first and only FDA-cleared hyaluronic acid injectable designed specifically for neck treatment.

How is Skinvive different from regular Juvéderm fillers?

Skinvive contains a lower concentration of cross-linked hyaluronic acid than traditional Juvéderm volumizers, making it optimized for the thinner, more mobile skin of the neck and décolletage. This formulation difference allows it to address the unique anatomical needs of the neck area.

How long does Skinvive last on the neck?

Clinical data shows sustained improvement in neck lines and skin quality at 12 weeks, with durability extending beyond six months in some patients. Individual results may vary based on metabolism and injection technique.

What was practitioners doing for neck fillers before Skinvive approval?

Before Skinvive's FDA approval, practitioners either used off-label filler applications or referred neck work to other providers. This created a clinical gap, as no hyaluronic acid injectable was specifically cleared for neck treatment until now.

Does Skinvive pricing affect practice revenue compared to facial fillers?

Neck treatment with Skinvive typically commands lower per-unit pricing than facial volumization, but it serves as a patient retention tool and case expansion opportunity in an area where competitors like Galderma and Revance have not yet secured comparable cleared indications.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $20/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://insidemedspa.com/article/skinvive-juvederm-fda-approval-neck/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa Pro

    By the time it's news, it's too late.

    The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

    Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
    The twice-a-week intelligence brief Go Pro · $20/mo